PERSPECTA

News from every angle

← Back to headlines

Wedbush Maintains Underperform Rating for Praxis Precision Medicines

Wedbush has maintained an "Underperform" rating on Praxis Precision Medicines, Inc. (PRAX).

12 May, 00:01 — 12 May, 00:01
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual108d ago

Wedbush Maintained an Underperform Rating on Praxis Precision Medicines, Inc. (PRAX)

Read full article →

Related Stories

BioNTech Ends Mid-Stage Colorectal Cancer Vaccine Trial

1h ago

Dolly Parton’s Sister Reveals Singer’s Final Cancer Battle and Generosity

2h ago

Second Victim Dies Following Catastrophic Fire in Omišu, Croatia

2h ago

UK Prime Minister Burnham to Abstain on Assisted Dying Bill

2h ago